Fastest Trial
The TIA stroke module was evaluated within the FASTEST trial (Efficacy and Safety of a TIA Electronic Support Tool) Published in Neurology (Ranta A, Dovey S, Weatherall M, O'Dea D, Gommans J, Tilyard M. Neurology. 2015 Apr 14;84(15):1545-51)


The implementation of the primary care based TIA/stroke electronic decisions support tool can improve TIA guideline adherence and reduce the risk of early recurrent stroke without compromising patient safety.


Multi-centre, single-blind, parallel, cluster randomized controlled trial (1:1) in New Zealand comparing management with and without Mosaic Consultation electronic decision support. GP initial diagnosis TIA or stroke (all included in analysis regardless of final diagnosis).


  • Improved adherence to best practice guidelines. Improved counselling.
  • Clinically important and statistically significant reductions in TIA or stroke at 90 days and any vascular event and death at 90 days.
  • Significant cost savings (NZ$1,479 per patient).
  • No increase of adverse safety events.

Click below to view a clinical module.

Reviews each patient record at the start of each consultation, undertakes risk assessments such as cancer risk assessments and identifies whether a patient should be considered for particular assessments, a clinical module or a clinical referral pathway.

Read More
Extensive range of clinical consultation support modules based on NICE adapted to local requirements for patients who have one or more clinical condition.

Read More
Extensive range of referral pathways that are based on local standards for patient referral management.

Read More